To access this element change to forms mode OFF
Grant Award View - GA206692
TARGETING COLD TUMOURS WITH TRIPLE THERAPY
GA ID:
GA206692
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
3-Nov-2021
Publish Date:
20-Dec-2021
Category:
Medical Research
Grant Term:
1-Jan-2022 to 31-Dec-2025
Value (AUD):
$1,624,510.40
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 20/21 1.1 Health and Medical Research
Grant Program:
Ideas Grants
Grant Activity:
TARGETING COLD TUMOURS WITH TRIPLE THERAPY
Purpose:
Patients with advanced metastatic disease have a very poor clinical outcome and are the main group of patients with an unmet clinical need. We know that very advanced cancers are resistant to the patient's immune system, and immune based therapies. In my program I will address these issues by (1) revealing how the patient's cancer avoids the immune system (2) create new types of T cells which will be resistant to the tumour immune evasion mechanisms (3) translate my findings into the clinic.
GO ID:
GO Title:
2021 Ideas Grants
Internal Reference ID:
2021/GNT2012263
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Melbourne
Recipient ABN:
84 002 705 224
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
ACT, VIC
Postcode:
Multiple
Country:
AUSTRALIA